Melanoma accounts for just 1% of skin cancer diagnoses but causes the majority of skin cancer deaths.1 Because of the heterogeneity of melanoma and unique genetic features of the cancer, prognosis and treatment can vary greatly. Accurate classification of melanoma is vital to understanding both the illness’s implications on the patient and the best treatment plan.
99K+ new melanomas diagnosed in 20221
~85 genetic loci associated with melanoma2
17 genes associated with melanoma included on the MayoComplete melanoma panel
Melanoma Test menu
Our MayoComplete melanoma panel uses next-generation sequencing to evaluate 17 melanoma-specific genes for variations related to diagnosis, prognosis, and tumor classification. Our team of board-certified geneticists and genetic counselors is available to assist with questions related to testing options and results interpretation.
Fill out the form below and one of our specialists will be in touch.